SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-04-000029
Filing Date
2004-09-16
Accepted
2004-09-16 17:03:51
Documents
2
Period of Report
2004-01-30
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8K FOR RICIN GRANT grant8k.htm 8-K 24552
2 RICIN GRANT PRESS RELEASE pressreleasegrant.htm EX-99.1 10036
  Complete submission text file 0000812796-04-000029.txt   36484
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 041034332
SIC: 2834 Pharmaceutical Preparations